retatrutide clinical studies Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial A New Obesity Drug Delivered
Description
Fatigue is reported by some patients using GLP-1 medications, but it's often temporary and manageable
Expect an adjustment period, possible dosage changes, and mild side effects, but overall, it's manageable.
Teva's generic liraglutide injection approved for adults with obesity and pediatric patients 12+ years
GLP-1s are shaking up the playbook and giving pharma companies a whole new set of moves to master
